Emerging Treatment Strategies in the Treatment of Cancer for Practicing Physicians and Healthcare Professionals

Module 4

This webcast is jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.

For more information visit: www.cancernetus.net


Eisai, Inc.
Onyx Pharmaceuticals, Inc., a subsidiary of Amgen, Inc.
Takeda Oncology
Genomic Health
Novartis Pharmaceuticals Corporation

Scroll to the Bottom of this Information to Begin this Course

Release date: Sept. 16, 2015

Valid through: Sept. 16, 2016

Specialty: Hematology/Oncology

Media: Internet

Estimated Time to Complete Activity: 1.25 hours

Target Audience

This webcast is directed primarily to hematologists/oncologists, radiation oncologists, surgical oncologists, pathologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new developments for treatment of selected solid tumors and hematological malignancies. No specific skill or knowledge other than a basic training in hematology/ oncology is required for successful participation in this activity.

Statement of Need / Program Overview

This webcast is intended to improve care of patients with selected solid tumors and hematological malignancies by accelerating adoption of new guidelines and evidence-based practice change.  In addition to chemotherapy and targeted therapy of lung and breast cancers, this symposium will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Utilize appropriate new therapeutic options in the management of malignant melanoma
  • Identify and utilize molecular targets and integration of targeted therapies for recurrent and/or metastatic squamous cell carcinoma of the head and neck

Credit Available

  • Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.


Michael Davies, MD, PhD, Associate Professor, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Merrill Kies, MD, Professor of Medicine, Deputy Division for MDAnderson Cancer Network, Divison of Cancer Medicine, Houston, TX

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet. The A. Webb Roberts Center for CME of Baylor Health Care System is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The A. Webb Roberts Center for Continuing Medical Education of Baylor Health Care System designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:

Michael Davies, MD, PhD
  • Advisory Board: GSK, Genentech, Novartis, Sanofi-aventis
  • Principal Investigator/Independent Contractor: GSK, Genentech, AstraZeneca, Sanofi-aventis, Merck, Myriad, Oncothyreon
Merrill Kies, MD
  • No relevant financial relationship

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME webcast:

John V. Heymach, MD, PhD
  • Advisory Board: Genentech, AstraZeneca, Novartis, GSK, Lilly USA, LLC, Boehringer Ingelheim, Synta, Exelixis
  • Research Support: AstraZeneca, GSK, Bayer
Kamatham A. Naidu, PhD (CancerNet)
  • No relevant financial relationships

All other individuals in a position to control content have no relevant financial relationships to disclose.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this webcast. During the period Sept. 16, 2015 through Sept. 16, 2016, participants must read all of the material and study the educational webcast.

Instructions For Course Participation

This webcast includes text, graphics, and may include multimedia features. There are no fees for participating in or receiving credit for this webcast.

Click on all of the "medical education webcast" links and review the content presented.  You must view all of the content to proceed to the post-test.

Read, complete, and submit answers to the post-test questions and evaluation questions online. You must answer all missed questions until you get them correct.

Participants must receive a test score of 100% in order to proceed to the course evaluation, and they must respond to all evaluation questions to receive a letter of credit.

If needed, you may save your answers and return to complete your course at a later date. You can find your saved course by selecting "My Courses" or through the main course catalog.

Letter Of Credit & Transcripts

After submitting the webcast evaluation you will have immediate access to view and download your letter of credit as a PDF. You may print the letter of credit, but you may not alter the letter of credit. You can access all your credit letters from the "My Courses" page

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the current versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player. Where such software is required it will be indicated.

CME Provider Privacy Policy and Contact Information

A. Webb Roberts Center for CME of Baylor Health Care System observes privacy and confidentiality of CME information and personal information of CME participants. Third parties receive only aggregated data about CME activities that are relevant to their interests and/or the activities they support. To contact CME Provider, call 214-820-2317.